An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk
2020 · Nature Communications · 245 citations
https://doi.org/10.1038/s41467-020-17673-9
X
Xiang Shu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
154
Papers
3.0K
Citations
32
h-index
62
i10-index
Xiang Shu is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Genetic Associations and Epidemiology & BRCA gene mutations in cancer & Nutrition, Genetics, and Disease. The author has an h-index of 32, co-authored 131 publications.
ORCID: 0000-0002-4129-9403Papers by this author
worksGenetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk
2018 · Cancer Research · 61 citations
https://doi.org/10.1158/0008-5472.can-18-2726
Prospective study of oral microbiome and gastric cancer risk among Asian, African American and European American populations
2021 · International Journal of Cancer · 57 citations
https://doi.org/10.1002/ijc.33847
Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer
2017 · Oncotarget · 50 citations
https://doi.org/10.18632/oncotarget.15609
<scp>P</scp>rospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk
2018 · International Journal of Cancer · 48 citations
https://doi.org/10.1002/ijc.31574
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2
2015 · Human Molecular Genetics · 47 citations
https://doi.org/10.1093/hmg/ddv035
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat